Joshua Reed

Currently holds a position at Aldeyra Therapeutics Inc

Position	Company	Period
Chief Financial Officer	Aldeyra Therapeutics Inc	July 27, 2018 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-05-30	2025-05-29	Scholar Rock Holding Corp (SRRK)	PlS Planned sale	15,885 -41.9% 87.96 US$1,233,762	15,885 -41.9%	87.96	US$1,233,762
2025-05-30	2025-05-29	Scholar Rock Holding Corp (SRRK)	PlS Planned sale	62,763 +34.8% 253.36 US$2,751,503	62,763 +34.8%	253.36	US$2,751,503
2025-05-29	2025-05-29	Scholar Rock Holding Corp (SRRK)	PrS Proposed sale	17,918 461.56 US$266,115	17,918	461.56	US$266,115
2019-09-09	2019-09-05	Aldeyra Therapeutics Inc (ALDX)	PP Planned purchase	3,200 +9.8% 4.71 US$15,072	3,200 +9.8%	4.71	US$15,072